ASH 2012 Report – New multiple myeloma drug shows promise in treating people with advanced disease
Therapy may be new option for hard-to-treat blood cancer.
Therapy may be new option for hard-to-treat blood cancer.
Proof-of-concept animal study selected as one of the best presentations at 54th American Society of Hematology Annual Meeting and Exposition.
Data demonstrate superior patient outcomes with B-R in first-line treatment of iNHL and MCL, compared with current standard of care.
Five additional studies presented at the 2012 Quality Care Symposium provided insight on how oncology practices can improve the quality of care they provide.
A new analysis has found that loading up on snack foods may increase cancer risk in individuals with an inborn susceptibility to colorectal and other cancers.
Unprecedented genomic sequencing of 14 metastatic TNBC patients yields potential drug targets
Researchers at Case Western Reserve University School of Medicine have identified a molecule linked to more aggressive forms of breast cancer – a discovery that could point the… read more.
There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among patients with prostate cancer at 12 months post-treatment according to a… read more.
Research presented at the American Society for Cell Biology (ASCB) annual meeting, 15-19 December 2012, San Francisco.
by Gary Finnegan – EMA Highlights – The EMA has given its backing to a number of medicines including:
by Gary Finnegan – EMA Highlights – The first radiopharmaceutical for positron emission tomography (PET) imaging of β-amyloid neuritic plaque density has been approved by the EMA’s Committee… read more.
by Gary Finnegan – EMA Highlights – The EMA has given the green light to a new vaccine for bacterial meningitis. Bexsero, by Novartis, provides broad coverage against… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.